AMLX
Amylyx Pharmaceuticals Inc
30.10$
-1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.47 | 1.57 | 1.31 | -0.02 | 0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.07 | 0.14 | 1.72 | 0.11 | 0.01 | 0.00 | 0.26 | 0.00 | 0.21 | 0.00 | 0.00 | – | – | |
| 1.40 | 1.43 | -0.41 | -0.13 | -0.01 | -0.01 | -0.26 | 0.00 | -0.21 | 0.00 | 0.00 | – | – | |
| 0.43 | 0.65 | 0.54 | 0.34 | 0.31 | 0.33 | 0.26 | 0.30 | 0.21 | 0.22 | 0.25 | 0.21 | 0.83 | |
| 0.70 | 0.62 | 0.85 | 0.32 | 0.26 | 0.21 | 0.18 | 0.18 | 0.17 | 0.16 | 0.15 | 0.20 | 0.63 | |
| 1.13 | 1.40 | 1.39 | 0.66 | 1.11 | 0.58 | 0.18 | 0.48 | 0.17 | 0.39 | 0.40 | 0.41 | 1.28 | |
| 0.27 | 0.03 | -1.80 | -0.79 | -1.11 | -0.59 | -0.44 | -0.48 | -0.39 | -0.39 | -0.40 | -0.41 | -1.46 | |
| – | 0.05 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.32 | 0.09 | -1.75 | -1.07 | -1.07 | -0.56 | -0.42 | -0.46 | -0.37 | -0.35 | -0.37 | -0.39 | -1.37 | |
| 0.02 | 0.03 | 0.00 | – | -1.07 | -0.01 | – | – | – | 0.00 | – | – | – | |
| 0.30 | 0.07 | -1.75 | -1.07 | -1.07 | -0.55 | -0.42 | -0.46 | -0.37 | -0.35 | -0.37 | -0.39 | -1.37 | |
| 0.33 | 0.10 | -1.74 | -1.07 | -1.06 | -0.55 | -0.42 | -0.46 | -0.37 | -0.33 | -0.37 | -0.39 | -1.35 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.